A new breast cancer drug has shown impressive results in shrinking tumours before surgery. Lapatinib (Tyverb) is licensed in the United States for advanced breast cancer but not in the European Union. It is similar to Herceptin in the way that it works – it inhibits the action of an emzyme that prompts the tumour to grow.
Link to Article
Additional Story
New drug Lapatinib shrinks breast cancer - The Times 18th April 2008
Friday, April 18, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment